1![Diagnostic Assay for Gastrointestinal stromal tumors (GIST) Background GIST can occur anywhere along the GI tract, but most often are found in the stomach or small intestine. Patients with GIST are treated by surgery and Diagnostic Assay for Gastrointestinal stromal tumors (GIST) Background GIST can occur anywhere along the GI tract, but most often are found in the stomach or small intestine. Patients with GIST are treated by surgery and](https://www.pdfsearch.io/img/a12d22ddef0e01f8966f9913593d4ec8.jpg) | Add to Reading ListSource URL: www.campus-technologies.deLanguage: English - Date: 2015-02-18 08:33:03
|
---|
2![AstraZeneca AZD0530 (saracatinib) Mechanism of Action AstraZeneca AZD0530 (saracatinib) Mechanism of Action](https://www.pdfsearch.io/img/0aa9960df9729299cc56c37a08db4048.jpg) | Add to Reading ListSource URL: www.ncats.nih.govLanguage: English - Date: 2015-02-11 13:23:13
|
---|
3![PRELIMINARY REPORT OF CRENOLANIB IN THE TREATMENT OF ADVANCED PLATELET DERIVED GROWTH FACTOR A (PDGFRA) D842V MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST) 1 Mehren , 2 PRELIMINARY REPORT OF CRENOLANIB IN THE TREATMENT OF ADVANCED PLATELET DERIVED GROWTH FACTOR A (PDGFRA) D842V MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST) 1 Mehren , 2](https://www.pdfsearch.io/img/35e3b3e66094d21a3a8b72f9820af714.jpg) | Add to Reading ListSource URL: www.gistsupport.orgLanguage: English - Date: 2013-01-18 17:46:23
|
---|
4![NCI Protocol #: PBTC-042 Local Protocol #: PBTC-042 Version date: 03 July 2014 Protocol Abstract and Schema PBTC-042: Phase I study of CDK 4-6 inhibitor PD[removed]in children with recurrent, NCI Protocol #: PBTC-042 Local Protocol #: PBTC-042 Version date: 03 July 2014 Protocol Abstract and Schema PBTC-042: Phase I study of CDK 4-6 inhibitor PD[removed]in children with recurrent,](https://www.pdfsearch.io/img/5e58073b124705f6162ba340f147e42b.jpg) | Add to Reading ListSource URL: www.pbtc.orgLanguage: English - Date: 2014-11-06 17:44:32
|
---|
5![Translational Medicine and New Therapies for the Treatment of GIST Brian Rubin, MD, PhD Anatomic Pathology and Molecular Genetics Translational Medicine and New Therapies for the Treatment of GIST Brian Rubin, MD, PhD Anatomic Pathology and Molecular Genetics](https://www.pdfsearch.io/img/d9ff1af2aa44ef30fa774a3954fa13f3.jpg) | Add to Reading ListSource URL: www.gistsupport.orgLanguage: English - Date: 2011-10-02 15:21:23
|
---|
6![CRENOLANIB, A NOVEL TYPE I, MUTANT-SPECIFIC INHIBITOR OF CLASS III RECEPTOR TYROSINE KINASES, PREFERENTIALLY BINDS TO PHOSPHORYLATED KINASES 1 CRENOLANIB, A NOVEL TYPE I, MUTANT-SPECIFIC INHIBITOR OF CLASS III RECEPTOR TYROSINE KINASES, PREFERENTIALLY BINDS TO PHOSPHORYLATED KINASES 1](https://www.pdfsearch.io/img/965e3e228a0b27196e47882e97a8efaf.jpg) | Add to Reading ListSource URL: www.gistsupport.orgLanguage: English - Date: 2013-01-20 11:10:44
|
---|